🇺🇸 FDA
Patent

US 9498432

Injectable flowable composition comprising buprenorphine

granted A61KA61K31/00A61K31/4748

Quick answer

US patent 9498432 (Injectable flowable composition comprising buprenorphine) held by Indivior UK Limited expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/00, A61K31/4748, A61K31/485, A61K47/22